Review on COVID-19 Vaccines
-
Published:2022-12-24
Issue:
Volume:
Page:5868-5874
-
ISSN:0974-360X
-
Container-title:Research Journal of Pharmacy and Technology
-
language:en
-
Short-container-title:RJPT
Author:
Majid Liyana1, Radhakrishnan Sengamalam1, Ramachandran Vignesh2, Muthukumarasamy Ravindran1
Affiliation:
1. Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, No. 3, Jalan Greentown, 30450 Ipoh, Perak Darul Ridzuan, Malaysia. 2. Faculty of Medicine, Universiti Kuala Lumpur Royal College of Medicine Perak, No. 3, Jalan Greentown, 30450 Ipoh, Perak Darul Ridzuan, Malaysia.
Abstract
Coronavirus disease 2019 (COVID-19) outbreak started in Wuhan, China when people started with the symptoms of respiratory disorder. The onset of this disease have symptoms like fever, dry cough, fatigue, and difficulty in breathing. The nature of SARS-CoV-2 seems highly contagious as it also can be spread with asymptomatically infected individuals. It has been more than a year which this outbreak have been announced as a pandemic by World Health Organization (WHO) due to major public health crisis and uncontrollable around the globe. Some countries have taken initiatives in inventing vaccines and step up in the clinical trial process since a vaccine is an all-powerful tool which it always been a saviour in fighting infectious disease. In searching for the vaccine, researchers had studied the previously published article of SARS-CoV or MERS as in the beginning, in light, there will be a suitable vaccine to fight this pandemic situation. Recent research on the vaccine has been tested to seek the right vaccine for COVID-19. This study is to focus on the current vaccine development against COVID-19 and to explore the potential vaccines’ characteristics that have been studied by the previous proven research findings. This review was done based on the research articles and reviews published until the end of April 2021 through established scientific search engines and related scientific platforms based on the inclusion criteria with its related keywords like coronavirus, SARS-CoV-2, COVID-19 Vaccine, clinical trials, and COVID-19 vaccine development. This review summarized a few vaccine candidates that have entered clinical trials and some supported evidence from Phase I until Phase III clinical trial studies that have been published and reported. In this review, 12 vaccine candidates have the potential to against SARS-CoV-2. Thus, their vaccine platform, characteristic as well as its efficacy studies have been discussed.
Publisher
A and V Publications
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference54 articles.
1. Kaur, S. P., and Gupta, V. (2020). COVID-19 Vaccine: A comprehensive status report. Virus Research, 1-12. doi:https://doi.org/10.1016/j.virusres.2020.198114. 2. Draft Landscape and Tracker of COVID-19 Candidate Vaccines. (2021). Retrieved from World Health Organization: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines 3. Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Qin, C. (2020). Development of an inactivated vaccine candidate for SARS-CoV-2. Science, 369, 77-81. 4. Zhang, Y., Zeng, G., Pan, H., Li, C., Hu, Y., Chu, K., Zhut, F. (2021). Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in Healthy Adults Aged 18–59 years: A Randomised, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial. The Lancet Infectious Disease, 21, 181-192. doi:https://doi.org/10.1016/S1473-3099(20)30843-4. 5. Bueno, S., Abarca, K., González, P., Gálvez, N., Soto, J., Duarte, L., Kalergis, A. (2021). Interim Report: Safety and Immunogenicity of an Inactivated Vaccine against SARS-CoV-2 in Healthy Chilean Adults in a Phase 3 Clinical Trial. medRxiv, 1-32. doi:https://doi.org/10.1101/2021.03.31.21254494
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|